![](https://img.einpresswire.com/small/546624/innorna-logo.jpeg)
Innorna Announces ODD Granted by the US FDA to IN016 for the Treatment of Progressive Familial Intrahepatic Cholestasis
UNITED STATES, August 1, 2024 /EINPresswire.com/ -- Innorna Announces Orphan Drug Designation Granted by the US FDA to IN016 for the Treatment of Progressive Familial Intrahepatic Cholestasis Innorna, a clinical-stage biotech company pioneering its …